[go: up one dir, main page]

AU2001251391A1 - Compositions and methods for promoting neural regeneration - Google Patents

Compositions and methods for promoting neural regeneration

Info

Publication number
AU2001251391A1
AU2001251391A1 AU2001251391A AU5139101A AU2001251391A1 AU 2001251391 A1 AU2001251391 A1 AU 2001251391A1 AU 2001251391 A AU2001251391 A AU 2001251391A AU 5139101 A AU5139101 A AU 5139101A AU 2001251391 A1 AU2001251391 A1 AU 2001251391A1
Authority
AU
Australia
Prior art keywords
compositions
methods
neural regeneration
promoting neural
promoting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001251391A
Other languages
English (en)
Inventor
Uri Herzberg
Veronica Mallon
Timothy James Neuberger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Acorda Therapeutics Inc
Original Assignee
Acorda Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acorda Therapeutics Inc filed Critical Acorda Therapeutics Inc
Publication of AU2001251391A1 publication Critical patent/AU2001251391A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2001251391A 2000-04-06 2001-04-06 Compositions and methods for promoting neural regeneration Abandoned AU2001251391A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19551600P 2000-04-06 2000-04-06
US60195516 2000-04-06
PCT/US2001/011220 WO2001076592A1 (fr) 2000-04-06 2001-04-06 Compositions et techniques favorisant la regeneration neuronale

Publications (1)

Publication Number Publication Date
AU2001251391A1 true AU2001251391A1 (en) 2001-10-23

Family

ID=22721702

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001251391A Abandoned AU2001251391A1 (en) 2000-04-06 2001-04-06 Compositions and methods for promoting neural regeneration

Country Status (3)

Country Link
US (2) US7271187B2 (fr)
AU (1) AU2001251391A1 (fr)
WO (1) WO2001076592A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1370253B8 (fr) * 2001-02-28 2008-11-26 Temple University of the Commonwealth System of Higher Education Utilisation d'arylsulfones alpha, beta non saturées pour la protection des cellules et des tissus contre la toxicite du rayonnement ionisant
CA2763775C (fr) 2002-05-10 2014-01-07 F. Hoffmann-La Roche Ag Acide bisphosphonique pour le traitement et la prevention de l'osteoporose
US7627373B2 (en) 2002-11-30 2009-12-01 Cardiac Pacemakers, Inc. Method and apparatus for cell and electrical therapy of living tissue
RU2315603C2 (ru) 2002-12-20 2008-01-27 Ф.Хоффманн-Ля Рош Аг Композиция с высокой дозой ибандроната
ITFI20030328A1 (it) * 2003-12-24 2005-06-25 Mario Bigazzi Uso della relaxina come adiuvante nella differenziazione
US7840263B2 (en) * 2004-02-27 2010-11-23 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression
US7764995B2 (en) 2004-06-07 2010-07-27 Cardiac Pacemakers, Inc. Method and apparatus to modulate cellular regeneration post myocardial infarct
US7828711B2 (en) * 2004-08-16 2010-11-09 Cardiac Pacemakers, Inc. Method and apparatus for modulating cellular growth and regeneration using ventricular assist device
US8060219B2 (en) 2004-12-20 2011-11-15 Cardiac Pacemakers, Inc. Epicardial patch including isolated extracellular matrix with pacing electrodes
US7981065B2 (en) 2004-12-20 2011-07-19 Cardiac Pacemakers, Inc. Lead electrode incorporating extracellular matrix
EP1976495A2 (fr) * 2006-01-06 2008-10-08 Aarhus Universitet Composes agissant sur le transporteur de la serotonine
WO2008118164A1 (fr) * 2007-03-23 2008-10-02 Zoltan Laboratories Llc Composés pour favoriser la régénération de la moelle osseuse
US7423029B1 (en) 2007-03-23 2008-09-09 Zoltan Laboratories, Llc Compounds to promote regeneration of bone marrow
US8452408B1 (en) * 2008-06-25 2013-05-28 University Of South Florida Promotion of brain self-repair mechanisms by stereotaxic micro-stimulation
US9332973B2 (en) 2008-10-01 2016-05-10 Covidien Lp Needle biopsy device with exchangeable needle and integrated needle protection
US11298113B2 (en) 2008-10-01 2022-04-12 Covidien Lp Device for needle biopsy with integrated needle protection
US8968210B2 (en) 2008-10-01 2015-03-03 Covidien LLP Device for needle biopsy with integrated needle protection
US9186128B2 (en) 2008-10-01 2015-11-17 Covidien Lp Needle biopsy device
US9782565B2 (en) 2008-10-01 2017-10-10 Covidien Lp Endoscopic ultrasound-guided biliary access system
US8640304B2 (en) * 2010-03-12 2014-02-04 G.B.D. Corp. Cyclone construction for a surface cleaning apparatus
US20140018299A1 (en) * 2012-07-10 2014-01-16 Banyan Biomarkers, Inc. Method and device to detect, monitor and promote neural regeneration and improvement of cognitive function in a subject suffering from neural injury

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4164412A (en) * 1971-02-24 1979-08-14 Minnesota Mining And Manufacturing Company Perfluoroalkylsulfonamidoaryl compounds
US4532349A (en) * 1982-08-25 1985-07-30 American Cyanamid Company 2-Amino-4'(phenylsulfonyl) acetanilides
US4965284A (en) * 1988-05-19 1990-10-23 American Cyanamid Company Substituted dibenzothiophenes
JP3243733B2 (ja) * 1996-08-07 2002-01-07 雪印乳業株式会社 新規イソキノリン誘導体
US6203711B1 (en) * 1999-05-21 2001-03-20 E. I. Du Pont De Nemours And Company Method for treatment of substantially aqueous fluids derived from processing inorganic materials
FR2802912B1 (fr) * 1999-12-27 2002-02-15 Eastman Kodak Co Procede pour preparer un polymere d'aluminosilicate

Also Published As

Publication number Publication date
US20020055530A1 (en) 2002-05-09
US20080070963A1 (en) 2008-03-20
US7271187B2 (en) 2007-09-18
WO2001076592A1 (fr) 2001-10-18

Similar Documents

Publication Publication Date Title
AU2001251391A1 (en) Compositions and methods for promoting neural regeneration
AU2001257095A1 (en) Patterned substrates and methods for nerve regeneration
AU3387599A (en) Methods and compositions for tissue regeneration
AU2001245437A1 (en) Lightweight methods and compositions for well treating
AU2001233168A1 (en) Neural regeneration conduit
AU2001275441A1 (en) Filter arrangement and methods
AU2001268126A1 (en) Compositions, kits, and methods for promoting defined health benefits
AU2001280599A1 (en) Compounds and methods
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
AU2001253418A1 (en) Compounds and methods
AU2001286651A1 (en) Microparticle composition and method
AU2002236626A1 (en) Compositions and methods for treating hyperpigmentation
AU2001279850A1 (en) Method and arrangement for studsystem
AU2002222240A1 (en) Nerve regeneration
AU2001243394A1 (en) Compounds and methods
AUPQ872300A0 (en) Compounds and methods
AU2001233932A1 (en) Method and composition
AU2002259162A1 (en) Method to induce neovascular formation and tissue regeneration
AU2001278951A1 (en) Compounds and methods
AU2001218024A1 (en) Methods for treating and preventing alopecia
AU2003214920A1 (en) Methods and compositions for treating hematological disorders
AU2002239775A1 (en) Chemical-library composition and method
AU2000274825A1 (en) Cosmetic method
AU2002235277A1 (en) Compounds and methods
AU2000273752A1 (en) Cosmetic method